Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma?

British Journal of Cancer

Volumn 73, Issue 7, 1996, Pages 945-950

  McMichael, A J ^a   Giles, G G ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

Author keywords

Epidemiology; Immune suppression; Melanoma; Non Hodgkin's lymphoma; Ultraviolet radiation

Indexed keywords

ARTICLE; CANCER REGISTRY; CAUCASIAN; FEMALE; HUMAN; IMMUNOMODULATION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MELANOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK; SKIN CANCER; SOLAR RADIATION; TIME; ULTRAVIOLET IRRADIATION;

EID: 0029970640     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.169     Document Type: Article

References (43)

1. ADAMI J, FRISCH M, YUEN J, GLIMELIUS B AND MELBYE M. (1995). Evidence of an association between non-Hodgkin's lymphoma and skin cancer. Br. Med. J., 310, 1491-1495.
2. ARMSTRONG BK AND KRICKER A (1993). How much melanoma is caused by sun exposure? Melanoma Res. , 3, 395-401.
3. ARMSTRONG BK AND KRICKER A. (1995). Skin cancer. Dermatoepidemiology, 13, 583-594.
4. BERG JW. (1967). The incidence of multiple primary cancers. 1. Development of further cancers in patients with lymphomas, leukemias and myelomas. J. Natl Cancer Inst., 38, 741-752.
5. CARTWRIGHT RA. (1992). Changes in the descriptive epidemiology of non-Hodgkin's lymphoma in Great Britain. Cancer Res., 52, (Suppl), 5441s-5442s.
6. CARTWRIGHT R, MCNALLY R AND STAINES A. (1994). The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight. Leukemia and Lymphoma, 14, 387-394.
7. COLEMAN M, ESTEVE J, DAMIECKI P, ARSLAN A AND RENARD H. (1993). Trends in Cancer Incidence and Mortality. International Agency for Research on Cancer: Lyon.
8. + epidermal macrophage induction and Langerhans cell depletion. Proc. Natl Acad. Sci. USA, 89, 8497-8501.
9. DEVESA SS AND FEARS T. (1992). Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res., 52, (Suppl), 5432s-5440s.
10. DIFFEY BL AND ELWOOD JM. (1994). Tables of ambient solar ultraviolet radiation for use in epidemiological studies of malignant melanoma and other disease. In Melanoma Epidemiology, Gallagher R and Elwood JM (eds). Klewer: New York.
11. DOLL R. (1991). Progress against cancer: an epidemiologic assessment. Am. J. Epidemiol., 134, 675-688.
12. FILIPOVICH AH, MATHUR A, KAMAT D AND SHAPIRO RS. (1992). Primary immunodeficiencies: genetic risk factors for non-Hodgkin's lymphoma. Cancer Res., 52, (Suppl), 5465s-5467s.
13. GIANNINI MSH. (1986). Suppression of pathogenesis in cutaneous leishmaniasis by UV irradiation. Infect. Immun., 51, 838-843.
14. GILES GG, FARRUGIA H, SILVER B AND STAPLES M. (1992). Cancer in Victoria 1982-1987. Anti-Cancer Council of Victoria: Melbourne.
15. GOETTSCH W, GARSSEN J, DE GRUIJL FR AND VAN LOVEREN H. (1993). UV-B and the immune system. A review with special emphasis on T cell-mediated immunity. Thymus, 21, 93-114.
16. GREINER TC. (1994). Epidemiology of non-Hodgkin's lymphoma: a review. Diagn. Oncol., 4, 26-32.
17. HARTGE P AND DEVESA SS. (1992). Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence. Cancer Res., 52, (Suppl), 5566s-5569s.
18. HARTGE P, DEVESA S AND FRAUMENI JF. (1994). Hodgkin's and non-Hodgkin's lymphomas. In Trends in Cancer Incidence and Mortality, Doll R, Fraumeni JF and Muir CS. (eds) pp. 423-453. Cold Spring Harbor Laboratory Press: New York.
19. HERSEY P, HAREN G, HASIC E AND EDWARDS A. (1983). Alteration of T cell subsets and induction of suppressor T cell activity in normal subjects after exposure to sunlight. J. Immunol., 31, 171-174.
20. HOLFORD TR, ZHENG T, MAYNE ST AND MCKAY LA. (1992). Time trends of non-Hodgkin's lymphoma: are they real? What do they mean? Cancer Res., 52, (Suppl), 5443s-5446s.
21. IARC. (1992). Solar and Ultraviolet Radiation. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 55. International Agency for Research on Cancer: Lyon.
22. JEEVAN A AND KRIPKE ML. (1990). Alteration of the immune response to Mycobacterium bovis BCG in mice exposed chronically to low doses of UV radiation. Cell. Immunol., 130, 32-41.
23. JEEVAN A AND KRIPKE ML. (1993). Ozone depletion and the immune system. Lancet, 342, 1159-1160.
24. KINLEN L. (1992). Immunosuppression and cancer. In Mechanisms of Carcinogenesis in Risk Identification, Vainio H, Magee PN, McGregor DB and McMichael AJ. (eds) pp. 237-253. IARC Scientific Publication No. 116. International Agency for Research on Cancer: Lyon.
25. KRIPKE ML. (1981). Immunologic mechanisms in UV radiation carcinogenesis. Adv. Cancer Res., 34, 69-81.
26. KRIPKE ML. (1994). Ultraviolet radiation and immunology: Something new under the sun. Cancer Res., 54, 6102-6105.
27. LLOYD SA. (1993). Stratospheric ozone depletion. Lancet, 342, 1156-1158.
28. MORISON WL. (1989). Effects of ultraviolet radiation on the immune system in humans. Photochem. Photobiol., 50, 515-524.
29. MORRISON HI, WILKINS K, SEMENCIW R, MAO AND WIGLE D (1992). Herbicides and cancer. J. Natl Cancer Inst., 84, 1866-1874.
30. MUIR CS, WATERHOUSE J, MACK T, POWELL J AND WHELAN SL (eds). (1987). Cancer Incidence in Five Continents. Vol. V. IARC Scientific Publications No. 88. International Agency for Research on Cancer: Lyon.
31. MUNAKATA N. (1993). Biologically effective dose of solar ultraviolet radiation estimated by spore dosimetry in Tokyo since 1980. Photochem. Photobiol., 58, 386-392.
32. NATIONAL CANCER INSTITUTE. (1985). Multiple Primary Cancers in Connecticut and Denmark. National Cancer Institute Monograph 68. National Cancer Institute: Bethesda, MD.
33. NOONAN FP AND DE FABO EC. (1990). Ultraviolet-B dose response curves for local and systemic immunosuppression are identical. Photochem. Photobiol., 452, 801-810.
34. OPELZ G AND HENDERSON R for the Collaborative Transplant Study. (1993). Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet, 342, 1514-1516.
35. PARKIN DM, MUIR CS, WHELAN SL, GAO Y-T, FERLAY J AND POWELL J. (eds). (1992). Cancer Incidence in Five Continents. Vol. VI. IARC Scientific Publications No. 120. International Agency for Research on Cancer: Lyon.
36. PEARCE N AND BETHWAITE P. (1992). Increasing incidence of non-Hodgkin's lymphoma: occupational and environmental factors. Cancer Res., 52, (Suppl), 5496s-5500s.
37. RABKIN CS, BIGGAR RJ AND HORM JW. (1991). Increasing incidence of cancers associated with human immunodeficiency virus epidemic. Int. J. Cancer, 47, 692-696.
38. RIVAS JM AND ULLRICH SE. (1994). The role of IL-4, IL-10, and TNFa in the immune suppression induced by ultraviolet radiation. J. Leuk. Biol., 56, 769-775.
39. SCHOTTENFELD D. (1982). Multiple primary cancers. In Cancer Epidemiology and Prevention, 1st ed., DR Schottenfeld and JR Fraumeni (eds) pp. 1025-1035. WB Saunders: Philadelphia.
40. SWERDLOW A AND DOS SANTOS SILVA I. (1994). Atlas of Cancer Incidence in England and Wales 1968 85. Oxford University Press: Oxford.
41. VAN DER ESCH EP, MUIR CS, NECTOUX G, MACFARLANE G, MAISONNEUVE P, BHARUCHA H, BRIGGS J, COOKE RA, DEMPSTER AG, ESSEX WB et al. (1991). Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int. J. Cancer. 47, 483-490.
42. VERMEER M, SCHMIEDER GJ, YOSHIKAWA T, VAN DEN BERG JW, METZMAN MS, TAYLOR JR AND STREILEIN JW. (1991). Effects of ultraviolet B light on cutaneous immune responses of humans with deeply pigmented skin. J. Invest. Dermatol., 97, 729-734.
43. YOSHIKAWA T, RAE V, BRUINS-SLOT W, VAN DEN BERG JW, TAYLOR JR AND STREILEIN JW. (1990). Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in man. J. Invest. Dermatol., 95, 530-536.